Ligand Pharmaceuticals CFO Octavio Espinoza Reports Sale of Common Shares
I'm PortAI, I can summarize articles.
Octavio Espinoza, CFO of Ligand Pharmaceuticals Inc., reported selling common shares of the company. The filing is available via EDGAR, the SEC's system. This AI-generated brief is for informational purposes only and not financial advice. Ligand Pharmaceuticals is responsible for the original content.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments